stoxline Quote Chart Rank Option Currency Glossary
  
AEON Biopharma, Inc. (AEON)
6.08  0.02 (0.33%)    12-07 16:00
Open: 6.08
High: 6.25
Volume: 5,556
  
Pre. Close: 6.06
Low: 5.85
Market Cap: 226(M)
Technical analysis
2023-12-07 4:18:49 PM
Short term     
Mid term     
Targets 6-month :  7.3 1-year :  8.53
Resists First :  6.25 Second :  7.3
Pivot price 5.39
Supports First :  4.77 Second :  3.85
MAs MA(5) :  6.01 MA(20) :  5.15
MA(100) :  0 MA(250) :  0
MACD MACD :  0.2 Signal :  0
%K %D K(14,3) :  89.5 D(3) :  89.3
RSI RSI(14): 64.3
52-week High :  9.39 Low :  3.36
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ AEON ] has closed below upper band by 19.0%. Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.09 - 6.11 6.11 - 6.13
Low: 5.99 - 6.02 6.02 - 6.04
Close: 6.02 - 6.06 6.06 - 6.1
Company Description

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Headline News

Thu, 07 Dec 2023
Midday Stock Roundup: Rivian Gets Buy Rating From Stifel - Orange County Business Journal

Thu, 19 Oct 2023
AEON Biopharma, Inc. Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the ... - Marketscreener.com

Thu, 19 Oct 2023
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive ... - BioSpace

Wed, 30 Aug 2023
Thinking about buying stock in Mullen Automotive, Traction Uranium, Aeon Biopharma, BigBear.ai Holdings, or Lumen ... - Marketscreener.com

Tue, 29 Aug 2023
AEON Biopharma Presents Positive Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia at the International Parkinson and Movement Disorders Society Congress® - Yahoo Finance

Mon, 07 Aug 2023
Evolus, Aeon Biopharma Tout Potential to Wall Street - Orange County Business Journal

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android